Early  radiologic  response  after  two  cycles  of  neoadjuvant   chemoimmunotherapy  and pathologic  outcomes  in  resectable  non-small  cell  lung  cancer: A multicenter retrospective study

An article created on 2026-08-19 09:48:32

#	Наименование новости	Информативность	Дата публикации
1	Neoadjuvant camrelizumab plus chemotherapy versus chemotherapy alone for resectable esophageal squamous cell carcinoma: A Prospective Multicenter randomised controlled study	13.06	19-08-2026
2	Clinical Outcomes of Epidermal Growth Factor Receptor (EGFR) Mutated Metastatic Non-Small Cell Lung Cancer in Kurdistan Region: A Retrospective Study	17.69	20-08-2026
3	The Role of Alveolar Pneumocytes in the Lung Microenvironment of Osteosarcoma Metastases	12.84	19-08-2026
4	Time to Sustained CEA Elevation From Start of First-Line Therapy Predicts Initial Treatment Efficacy and Clinical Outcomes in Lung Adenocarcinoma	17.69	20-08-2026
5	NLRP4–ER Stress–CCL5 axis as a translational target for NK cell-based immunotherapy in lung cancer	25	19-08-2026
6	Sex-Associated Plasma Cell-Free DNA Methylation Patterns in Indonesian Lung Cancer: An Exploratory Study	23.93	20-08-2026
7	Repeat Breast-Conserving Surgery with Re-irradiation for Ipsilateral Breast Tumor Recurrence After Initial Breast-Conserving Therapy: A Meta-Analysis of 25 Studies	32.26	19-08-2026
8	Immunogenicity evaluation of mutant peptides identified from lung cancer patients	16.25	20-08-2026
9	Neoadjuvant Immune Checkpoint Inhibitors in Early Breast Cancer	7.64	01-10-2024
10	Pathologic Response After Neoadjuvant Chemoimmunotherapy in Head and Neck Squamous Cell Carcinoma	4.44	13-08-2026

Классификация: Информация. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 17.14. Источник: www.researchsquare.com.

Найдите то, что Вас интересует